Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
14
Participants
Timeline
Start Date
March 9, 2018
Primary Completion Date
April 13, 2018
Study Completion Date
April 13, 2018
Conditions
Lactose Intolerance
Interventions
DRUG
RP-G28
RP-G28 is a purified galacto-oligosaccharide (GOS) product
Trial Locations (1)
33136
Syneos Health, Miami
All Listed Sponsors
lead
Ritter Pharmaceuticals, Inc.
INDUSTRY
NCT03563846 - Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects | Biotech Hunter | Biotech Hunter